ACE and diabetic kidney disease: The activation of the classical RAS (via ACE activity) promotes inflammation and fibrosis, but the non-classical pathway (via ACE2 activity) protects against diabetic nephropathy (Mori et al., 2014; Oudit et al., 2010; Soler et al., 2007).